Literature DB >> 29545428

Metastatic primary pulmonary melanoma successfully treated with checkpoint inhibitors.

Georges Al-Helou1, Nardos Temesgen1, Jonathan Gwizdala1, Jalil Ahari1.   

Abstract

Our patient is a 69-year-old man who presented to the emergency department with left-sided hemiparesis that started 4 hours prior to presentation. Brain CT showed right basal ganglia and internal capsule haemorrhagic strokes. MRI revealed multiple brain lesions suspicious for metastases. Further workup revealed a 5 cm lung mass and a 1 cm pancreatic nodule. Biopsy of both pulmonary and pancreatic lesions was consistent with melanoma and was similar histologically. The patient underwent cyberknife stereotactic radiosurgery to the brain metastases followed by immunotherapy with pembrolizumab, and then by nivolumab and ipilimumab. The patient remains free of disease progression 2 years after treatment. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cancer intervention; lung cancer (oncology); respiratory medicine

Mesh:

Substances:

Year:  2018        PMID: 29545428      PMCID: PMC5878353          DOI: 10.1136/bcr-2017-223025

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

1.  Nivolumab in previously untreated melanoma without BRAF mutation.

Authors:  Caroline Robert; Georgina V Long; Benjamin Brady; Caroline Dutriaux; Michele Maio; Laurent Mortier; Jessica C Hassel; Piotr Rutkowski; Catriona McNeil; Ewa Kalinka-Warzocha; Kerry J Savage; Micaela M Hernberg; Celeste Lebbé; Julie Charles; Catalin Mihalcioiu; Vanna Chiarion-Sileni; Cornelia Mauch; Francesco Cognetti; Ana Arance; Henrik Schmidt; Dirk Schadendorf; Helen Gogas; Lotta Lundgren-Eriksson; Christine Horak; Brian Sharkey; Ian M Waxman; Victoria Atkinson; Paolo A Ascierto
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

2.  Acute pancreatitis revealing diffuse infiltration of the pancreas by melanoma.

Authors:  R Sobesky; J C Duclos-Vallée; F Prat; G Pelletier; R Encaoua; V Boige; J Fritsch; L Castera; P Bedossa; C Buffet
Journal:  Pancreas       Date:  1997-08       Impact factor: 3.327

3.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

4.  Primary melanoma of the lung.

Authors:  M S Allen; E C Drash
Journal:  Cancer       Date:  1968-01       Impact factor: 6.860

5.  Primary malignant melanoma of the bronchus.

Authors:  D J Farrell; A P Kashyap; T Ashcroft; G N Morritt
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

6.  Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

Authors:  James Larkin; Vanna Chiarion-Sileni; Rene Gonzalez; Jean Jacques Grob; C Lance Cowey; Christopher D Lao; Dirk Schadendorf; Reinhard Dummer; Michael Smylie; Piotr Rutkowski; Pier F Ferrucci; Andrew Hill; John Wagstaff; Matteo S Carlino; John B Haanen; Michele Maio; Ivan Marquez-Rodas; Grant A McArthur; Paolo A Ascierto; Georgina V Long; Margaret K Callahan; Michael A Postow; Kenneth Grossmann; Mario Sznol; Brigitte Dreno; Lars Bastholt; Arvin Yang; Linda M Rollin; Christine Horak; F Stephen Hodi; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2015-05-31       Impact factor: 91.245

Review 7.  Emerging trends in the epidemiology of melanoma.

Authors:  V Nikolaou; A J Stratigos
Journal:  Br J Dermatol       Date:  2014-01       Impact factor: 9.302

Review 8.  Stereotactic radiosurgery in the treatment of brain metastases: the current evidence.

Authors:  Bodo Lippitz; Christer Lindquist; Ian Paddick; David Peterson; Kevin O'Neill; Ronald Beaney
Journal:  Cancer Treat Rev       Date:  2013-06-27       Impact factor: 12.111

9.  Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib.

Authors:  Georgina V Long; Jeffrey S Weber; Jeffrey R Infante; Kevin B Kim; Adil Daud; Rene Gonzalez; Jeffrey A Sosman; Omid Hamid; Lynn Schuchter; Jonathan Cebon; Richard F Kefford; Donald Lawrence; Ragini Kudchadkar; Howard A Burris; Gerald S Falchook; Alain Algazi; Karl Lewis; Igor Puzanov; Nageatte Ibrahim; Peng Sun; Elizabeth Cunningham; Amy S Kline; Heather Del Buono; Diane Opatt McDowell; Kiran Patel; Keith T Flaherty
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

10.  Cerebral metastases from malignant melanoma: current treatment strategies, advances in novel therapeutics and future directions.

Authors:  Timothy L Siu; Suyun Huang
Journal:  Cancers (Basel)       Date:  2010-04-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.